|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/192 | |
| A61K 31/197 | |||
| A61K 31/4164 | |||
| A61K 31/4178 | |||
| A61K 31/436 | |||
| A61K 31/485 | |||
| A61K 31/575 | |||
| A61K 31/7004 | |||
| A61P 25/14 | |||
| A61P 25/16 | |||
| A61P 25/18 | |||
| A61P 25/24 | |||
| A61P 25/28 | |||
| A61K 45/06 |
| (11) | Number of the document | 2823817 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14176796.2 |
| Date of filing the European patent application | 2010-05-28 | |
| (97) | Date of publication of the European application | 2015-01-14 |
| (45) | Date of publication and mention of the grant of the patent | 2017-06-21 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 09305506 | 2009-06-02 | EP |
| (72) |
Cohen, Daniel, FR
Nabirochkin, Serguei, FR
Chumakov, Ilya, FR
|
| (73) |
Pharnext,
11, rue des Peupliers, 92130 Issy-les-Moulineaux,
FR
|
| (54) | New compositions for treating CMT and related disorders |
| New compositions for treating CMT and related disorders |